Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- PBC Spotlight: Outstanding Accomplishments in Life Science Research from ASU, NAU and U of A
- How AI — and ASU — will advance the health care sector
- Exploring the Intersection of Sleep Medicine and COVID Recovery
- TGen’s Keri Ramsey named recipient of 2024 Claire Chee Award for Excellence in Child Neurology Nursing
- Helitzer stepping down as dean of ASU College of Health Solutions
- City of Phoenix unanimously voted to invest $20 million in the continued growth of life science research in downtown Phoenix
- ASU College of Health Solutions brings back Nutrition Bowl with NAU team coming out on top